Beltrand, Jacques <br/><br/>
Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations.  [electronic resource] 

 -  Diabetes care  Nov 2015 
 - 2033-41 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1935-5548 
<br/><br/><label>Standard No.: </label>10.2337/dc15-0837  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adolescent<br/>Brain--pathology<br/>Child<br/>Child, Preschool<br/>Diabetes Mellitus--drug therapy<br/>Drug Substitution<br/>Female<br/>Glyburide--administration & dosage<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Infant<br/>Infant, Newborn<br/>Insulin--administration & dosage<br/>Magnetic Resonance Imaging<br/>Male<br/>Mutation<br/>Neurologic Manifestations<br/>Neuropsychological Tests<br/>Potassium Channels, Inwardly Rectifying--genetics<br/>Psychomotor Performance<br/>Sulfonylurea Receptors--genetics